For the past few years, notoginsenoside R1 could retard DN by ameliorating podocyte adhesion through α3β1 integrin upregulation and astragaloside IV could inhibit podocyte apoptosis by downregulation of PERK-ATF4-CHOP pathway [71, 72]. Here, EIF2AK3 is linked to liver dysplastic nodule.